| Symbol | MNKA |
|---|---|
| Name | MANUKA, INC. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | 4959507 Israel 3 Eliezer Vardinon St. |
| Telephone | (646) 233-1454 |
| Fax | — |
| — | |
| Website | https://investors.bmanuka.com |
| Incorporation | US |
| Incorporated On | 2017 |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | Deloitte Brightman Almagor Zohar; |
| Audit Status | AUDITED |
| Reporting Status | U.S. Reporting: SEC Reporting |
| CIK | 0001062128 |
| Description | Manukas business activities primarily consist of developing and manufacturing skincare products based on New Zealands Manuka honey and bee venom, among other natural ingredients. All of Manukas products are marketed and sold on the internet. Manukas skincare products are manufactured in Israel. Manuka plans to distribute its products in the U.S. market, based on permits granted by the U.S. Food and Drug Administration. Additional info from OTC: |
No news found.